- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02080702
An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract (PROMEGAT)
An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract.
The aim of this non-interventional study is to evaluate the efficacy of a monofilament, mid-term absorbable suture material (Monosyn®) for anastomosis performed in the gastrointestinal tract using the frequency of anastomosis leakage as a primary parameter.
Postoperative complication rate, length of hospital stay, costs, time to perform the anastomosis and handling will serve as secondary endpoints.
The question is addressed, whether a monofilament suture material is as effective as a braided suture material for anastomosis construction within the gastrointestinal tract.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Gangnam-Gu, Seoul, Korea, Republic of, 135-72
- Gangnam Severance Hospital
-
Gyeonggi-do, Korea, Republic of, 463-707
- Seoul National University Bundang Hospital
-
-
-
-
-
Kuala Lumpur, Malaysia, 59100
- University Malaya Medical Centre
-
-
-
-
-
Manila, Philippines
- Philippine General Hospital
-
-
-
-
-
Taipei City, Taiwan, 112 Beitou District
- Veterans General Hospital-Taipei
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 years and older
- ASA I-III
- Indication for an elective tumor surgery within the GI tract (stomach, small intestine, large intestine)
- Written informed consent
Exclusion Criteria:
- Emergency surgery
- Peritonitis
- Patients undergoing an operation due to a tumour within the pancreas, rectum, esophagus
- Pregnant women and breast-feeding women
- Chemotherapy
- Current immunosuppressive therapy
- Radiotherapy on the treated region within the last 2 months
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Monosyn
Construction of a gastrointestinal anastomoses
|
Monosyn will be used to perform the gastrointestinal anastomoses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of anastomosis leakage rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Anastomotic leak is defined as radiographic demonstration of a fistula or non-absorbable material drainage from a wound after oral administration, or visible disruption of the suture line during re-exploration.
|
participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative complication rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
|
As postoperative complications the following parameter will be documented: peritonitis, wound infection, bleeding, abscess, fistula, perforation, obstipation and stenosis.
Wound infections, peritonitis and abscess are defined according to the Centres for Disease Control and Prevention (CDC, 17).
|
participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Reoperation rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
|
participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Length of hospital stay
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
|
Duration from day of operation until the day of discharge from the hospital.
|
participants will be followed for the duration of hospital stay, an expected average of 10 days
|
Stay in the intensive care unit
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Duration from the first day in the ICU until the last day in the ICU.
In the case of readmission to the ICU the sum of all days within the ICU.
|
participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Duration to perform the anastomosis
Time Frame: intraoperatively
|
The time recorded for the construction of the anastomosis begins with the placement of the first stitch and ends with cutting the excess material from the last stitch.
|
intraoperatively
|
Cost
Time Frame: duration of the intervention (approximately 18 months)
|
Calculation of the cost of material is based on the actual hospital costs for the suture material and the number of used threads by the surgeon. For the calculation of the operation costs, the time to perform the anastomosis will be multiplied with the cost of one operation minute (50-100 €). |
duration of the intervention (approximately 18 months)
|
Handling of the device
Time Frame: End of the Study (approximately 18 months)
|
Intra-operative handling of the suture material will be reported on a separate document one time per participating surgeon at the end of the study. The following criteria will be assessed: knot security, knot pull tensile strength, knot run-down, tissue drag, elasticity and feeling of the suture material. For the rating a 5-point scale is used |
End of the Study (approximately 18 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAG-O-H-1209
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Neoplasms
-
Novartis PharmaceuticalsActive, not recruitingNeoplasms, Gastrointestinal TractChina, Canada, Estonia, Italy, Turkey, Argentina, Israel, Netherlands, Poland, Russian Federation, Thailand, Brazil, Chile, Hong Kong, Hungary, India, Mexico, Peru, Taiwan, Ukraine, United States, Korea, Republic of, Puerto Rico
-
Shanghai Juncell TherapeuticsShanghai 10th People's HospitalRecruiting
-
Sun Yat-sen UniversityUnknownGastrointestinal CancersChina
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Peking University Cancer Hospital & InstituteActive, not recruitingGastrointestinal CancerChina
-
Brigette MaRecruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdJiangsu Alphamab Biopharmaceuticals Co., LtdRecruitingAdvanced Gastrointestinal TumorsChina
-
Boehringer IngelheimCompletedGastrointestinal Cancer, MetastaticBelgium, United States, France, Japan, China
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Henan Cancer HospitalUnknownAdvanced Gastrointestinal TumorsChina
Clinical Trials on Monosyn
-
Aesculap AGB.Braun Surgical SACompletedPediatric and Adult: Mucosal Closure in Facial and Oral Surgery | Pediatric and Adult: Skin Closure (Dermal Sutures) | Women: Episiotomy | Pediatric: Urological Interventions (Circumcision, Phimosis Etc.)Germany
-
Tufts Medical CenterCompleted
-
Aesculap AGB.Braun Surgical SARecruitingPeriodontal Diseases | Gingivitis | Gingival DiseasesSpain